Madrigal Pharmaceuticals, Inc.
Overview
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for cardiovascular, metabolic, and liver-related diseases. The company's lead product candidate is aimed at treating non-alcoholic steatohepatitis (NASH) and other diseases characterized by fatty liver.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Madrigal Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.